POTASSIUM CHLORIDE

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: POTASSIUM CHLORIDE
Generic name: POTASSIUM CHLORIDE
Manufacturer: Granules Pharmaceuticals Inc.
Product type: HUMAN PRESCRIPTION DRUG
SPL set ID: 302b3fa7-ea87-4bf1-aae0-6a2d7459de86
SPL ID: 44f3fc8c-926c-1505-e063-6294a90a88fd
Version: 4
Effective date: 2025-12-02
Source export date: 2026-09-28
Source partition: 6
Source file: https://download.open.fda.gov/drug/label/drug-label-0006-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-09-28/e0861bcde1444ef952820955caafc6f3fd29783e5ade07a13d933aa3336b399f/drug-label-0006-of-0014.json.zip
Source manifest SHA-256: cd2e66336a5cd2223fa3995098fdbdb84c6a7ee5c0a4addb236ccb22dd1e6887
Import run: 20260929T050834Z
Imported at: 2026-09-29 05:38:03

Harmonized routes table
Harmonized routes
ORAL

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 16 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
application applno	ANDA	213392	derived:openfda.application_number
application number		ANDA213392	openfda.application_number
brand name		POTASSIUM CHLORIDE	openfda.brand_name
generic name		POTASSIUM CHLORIDE	openfda.generic_name
manufacturer name		Granules Pharmaceuticals Inc.	openfda.manufacturer_name
ndc	package	70010-073-44	openfda.package_ndc
ndc	package	70010-072-44	openfda.package_ndc
ndc	product	70010-072	openfda.product_ndc
ndc	product	70010-073	openfda.product_ndc
ndc11	package	70010007244	derived:openfda.package_ndc
ndc11	package	70010007344	derived:openfda.package_ndc
rxcui		314182	openfda.rxcui
rxcui		312515	openfda.rxcui
spl id		44f3fc8c-926c-1505-e063-6294a90a88fd	id
spl set id		302b3fa7-ea87-4bf1-aae0-6a2d7459de86	set_id
unii		660YQ98I10	openfda.unii

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings and cautions

5 WARNINGS AND PRECAUTIONS • Gastrointestinal Irritation: Dilute before use, take with meals (5.1) 5.1 Gastrointestinal Irritation May cause gastrointestinal irritation if administered undiluted. Increased dilution of the solution and taking with meals may reduce gastrointestinal irritation [ see Dosage and Administration (2.1 )].

Adverse reactions cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Adverse reactions sections page 1 of 1 · 1 matching rows.

adverse reactions

6 ADVERSE REACTIONS The most common adverse reactions to oral potassium salts are nausea, vomiting, flatulence, abdominal pain/discomfort, and diarrhea. Most common adverse reactions are nausea, vomiting, flatulence, abdominal pain/discomfort and diarrhea. (6) To report SUSPECTED ADVERSE REACTIONS, contact Granules Pharmaceuticals Inc., at 1-877-770-3183 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.